Dextran-Sulfate Plasma Adsorption Lipoprotein Apheresis in Drug Resistant Primary Focal Segmental Glomerulosclerosis Patients: Results From a Prospective, Multicenter, Single-Arm Intervention Study

• Egile Nagusiak: Rupesh Raina (Egilea), Vinod Krishnappa (Egilea), Cheryl Sanchez-Kazi (Egilea), Alejandro Quiroga (Egilea), Katherine E. Twombley (Egilea), Robert Mathias (Egilea), Megan Lo (Egilea), Ronith Chakraborty (Egilea), Shefali Mahesh (Egilea), Julia Steinke (Egilea), Timothy Bunchman (Egilea), Joshua Zaritsky (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2019-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Focal segmental glomerulosclerosis (FSGS) causes end stage renal disease (ESRD) in significant proportion of patients worldwide. Primary FSGS carries poor prognosis and management of FSGS patients, refractory to standard treatments or resistant to steroids, remains a major challenge. Lip...